<DOC>
	<DOCNO>NCT02830776</DOCNO>
	<brief_summary>Topical bimatoprost show cause periorbital change soft tissue pronounce use directly onto cornea treatment glaucoma . Changes primarily felt result prostaglandin-mediated adipocyte loss , result deepen upper eyelid sulcus recession infraorbital pseudoherniation . Use topical bimatoprost upper eyelid margin , FDA approve eyelash enhancement , may provide metered effect periocular tissue allow topical approach periocular rejuvenation . This proof concept study aim enroll series patient mild severe dermatochalasis , treat topical bimatoprost 0.03 % solution upper lid margin , evaluate cosmetic improvement periocular area .</brief_summary>
	<brief_title>Topical Bimatoprost Chemical Blepharoplasty</brief_title>
	<detailed_description>Perception beauty periocular region influence several factor , include symmetry , population norm , skin texture tone . Soft tissue skin change time create age appearance development dermatochalasis , blepharoptosis , lacrimal gland prolapse , fat prolapse . Techniques periocular rejuvenation well establish include soft tissue augmentation , resurface , surgical correction . In May 2015 , Sarnoff Gotkin report case `` chemical blepharoplasty '' achieve topical bimatoprost ophthalmic 0.03 % solution apply upper eyelid margin . After three month use , author note youthful appearance periocular region , deepen upper eyelid sulcus , reduction dermatochalasis , diminution inferior eyelid fat pad . These change attribute prostaglandin associate periorbitopathy ( PAP ) , well describe phenomenon observe use topical prostaglandin analogue use glaucoma . Periorbital change observe topical prostaglandin analogue primarily due effect aponeurotic deep orbital adipocytes . Prostaglandins activate adipocyte mitogen-activated protein kinase ( MAPK ) pathway , lead inactivation peroxisome proliferator-activated receptor ( PPAR ) -gamma , inhibition adipocyte differentiation , decrease fat accumulation within adipocytes . Bimatoprost concentration-dependent contraction ciliary muscle activation matrix metalloproteinases may also contribute periocular change . Patients use topical ophthalmic prostaglandin analogue commonly develop periorbital fat loss , well characterized ophthalmology literature . Bimatoprost apply upper eyelid margin eyelash enhancement attempt capitalize desirable effect darker , long , thicker eyelash , limit significant undesirable effect limited exposure drug ocular tissue . This concept may apply dermatochalasis : meter dose , topical bimatoprost lid margin could lead subtle periorbital fat loss result improved dermatochalasis .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>18+ , mild severe dermatochalasis , desire enhance eyelash . Patients current use ophthalmic prostaglandin analogue , history blepharoplasty , history neuromodulators filler periocular region frontalis last 6 month , exist deep upper eyelid sulcus , opposition eyelash enhancement , pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>dermatochalasis</keyword>
	<keyword>bimatoprost</keyword>
	<keyword>blepharoplasty</keyword>
</DOC>